☰

Jessica D. Schulte, Ph.D. - Publications

Affiliations: 
2012 Neuroscience Institute Graduate Program Northwestern University, Evanston, IL 
Area:
Developmental Neuroscience
Tree Info Grants Similar researchers PubMed Report error

4/19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Schulte JD, Aghi MK, Taylor JW. Anti-angiogenic therapies in the management of glioblastoma. Chinese Clinical Oncology. PMID 32389001 DOI: 10.21037/Cco.2020.03.06  0.318
2013 Schulte JD, Srikanth M, Das S, Zhang J, Lathia JD, Yin L, Rich JN, Olson EC, Kessler JA, Chenn A. Cadherin-11 regulates motility in normal cortical neural precursors and glioblastoma. Plos One. 8: e70962. PMID 23951053 DOI: 10.1371/Journal.Pone.0070962  0.621
2013 Agarwal M, Nitta R, Dovat S, Li G, Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, ... ... Schulte J, et al. CELL BIOLOGY AND SIGNALING Neuro-Oncology. 15: iii12-iii31. DOI: 10.1093/Neuonc/Not174  0.619
2010 Mutch CA, Schulte JD, Olson E, Chenn A. Beta-catenin signaling negatively regulates intermediate progenitor population numbers in the developing cortex. Plos One. 5: e12376. PMID 20811503 DOI: 10.1371/Journal.Pone.0012376  0.481
Low-probability matches (unlikely to be authored by this person)
2019 Donovan L, Gedailovich S, Joanta-Gomez A, Schulte J, Kreisl TN, Lassman AB, Welch MR, Haggiagi A, Iwamoto FM. Hyperprogressive disease in patients with recurrent high grade gliomas treated with immune checkpoint inhibitors or other therapies. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E13575  0.236
2017 Odia Y, Schulte J, Iwamoto F. Abstract CT102: Rates and impact of combination immunotherapy with tumor treating fields in a glioma cohort Clinical Trials. 77. DOI: 10.1158/1538-7445.Am2017-Ct102  0.236
2018 Schulte JD, Hargus G, Canoll P, Sisti MB, Wang TJC, Lignelli A, Lassman AB. Clinical Reasoning: Transient speech deficits in a patient with history of medulloblastoma. Neurology. 91: e1196-e1201. PMID 30224509 DOI: 10.1212/Wnl.0000000000006202  0.181
2020 Morshed RA, Reihl SJ, Molinaro AM, Kakaizada S, Young JS, Schulte JD, Butowski N, Taylor J, Bush NA, Aghi MK, Berger MS, Chang S, Clarke J, Hervey-Jumper SL. The influence of race and socioeconomic status on therapeutic clinical trial screening and enrollment. Journal of Neuro-Oncology. PMID 32350780 DOI: 10.1007/S11060-020-03503-X  0.181
2016 Schulte J, Sawas A. RARE-62. INTRAVASCULAR LYMPHOMA WITH CNS INVOLVEMENT SUCCESSFULLY TREATED WITH R-CODOX-M/IVAC Neuro-Oncology. 18: vi171-vi172. DOI: 10.1093/Neuonc/Now212.718  0.181
2022 Choudhury A, Magill ST, Eaton CD, Prager BC, Chen WC, Cady MA, Seo K, Lucas CG, Casey-Clyde TJ, Vasudevan HN, Liu SJ, Villanueva-Meyer JE, Lam TC, Pu JK, Li LF, ... ... Schulte JD, et al. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nature Genetics. PMID 35534562 DOI: 10.1038/s41588-022-01061-8  0.179
2011 Seidel G, Böcker K, Schulte J, Wewer C, Greune L, Humberg V, Schmidt MA. Pertussis toxin permeabilization enhances the traversal of Escherichia coli K1, macrophages, and monocytes in a cerebral endothelial barrier model in vitro. International Journal of Medical Microbiology : Ijmm. 301: 204-12. PMID 21115396 DOI: 10.1016/j.ijmm.2010.08.018  0.162
2022 Young JS, Kidwell RL, Zheng A, Haddad AF, Aghi MK, Raleigh DR, Schulte JD, Butowski NA. CDK 4/6 inhibitors for the treatment of meningioma. Frontiers in Oncology. 12: 931371. PMID 35936751 DOI: 10.3389/fonc.2022.931371  0.122
2023 Stasenko A, Kaestner E, Rodriguez J, Kohli JS, Farid N, Goodwill V, Schwartz MS, Schulte JD, McDonald CR. Memory deficit following resection of an intraventricular myxoid glioneuronal tumor impinging on the bilateral fornix: A case report. Frontiers in Oncology. 13: 1263556. PMID 37829343 DOI: 10.3389/fonc.2023.1263556  0.101
2020 Schulte JD, Buerki RA, Lapointe S, Molinaro AM, Zhang Y, Villanueva-Meyer JE, Perry A, Phillips JJ, Tihan T, Bollen AW, Pekmezci M, Butowski N, Oberheim Bush NA, Taylor JW, Chang SM, et al. Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults. Neuro-Oncology Advances. 2: vdaa142. PMID 33354667 DOI: 10.1093/noajnl/vdaa142  0.098
2023 Chen WC, Choudhury A, Youngblood MW, Polley MC, Lucas CG, Mirchia K, Maas SLN, Suwala AK, Won M, Bayley JC, Harmanci AS, Harmanci A, Klisch TJ, Nguyen MP, Vasudevan HN, ... ... Schulte J, et al. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nature Medicine. PMID 37944590 DOI: 10.1038/s41591-023-02586-z  0.096
2021 Mende AL, Schulte JD, Okada H, Clarke JL. Current Advances in Immunotherapy for Glioblastoma. Current Oncology Reports. 23: 21. PMID 33496872 DOI: 10.1007/s11912-020-01007-5  0.095
2023 Raleigh D, Chen W, Choudhury A, Youngblood M, Polley MY, Lucas CH, Mirchia K, Maas S, Suwala A, Won M, Bayley J, Harmanci A, Harmanci A, Klisch T, Nguyen M, ... ... Schulte J, et al. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Research Square. PMID 36993741 DOI: 10.21203/rs.3.rs-2663611/v1  0.095
2004 Johnson LM, Schulte JD. Job: security. 7 steps for HIPAA compliance. Healthcare Financial Management : Journal of the Healthcare Financial Management Association. 58: 46-9. PMID 15524033  0.042
2002 Linnemannstöns P, Schulte J, del Mar Prado M, Proctor RH, Avalos J, Tudzynski B. The polyketide synthase gene pks4 from Gibberella fujikuroi encodes a key enzyme in the biosynthesis of the red pigment bikaverin. Fungal Genetics and Biology : Fg & B. 37: 134-48. PMID 12409099 DOI: 10.1016/S1087-1845(02)00501-7  0.016
Hide low-probability matches.